IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 28 filers reported holding IMMUNE DESIGN CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,441,000 | -50.6% | 443,790 | -31.9% | 0.00% | -100.0% |
| Q3 2016 | $4,940,000 | +10.1% | 651,726 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $4,486,000 | -38.1% | 549,736 | -1.4% | 0.00% | -50.0% |
| Q1 2016 | $7,247,000 | -33.1% | 557,427 | +3.3% | 0.00% | 0.0% |
| Q4 2015 | $10,837,000 | +199.6% | 539,686 | +82.0% | 0.00% | +100.0% |
| Q3 2015 | $3,617,000 | -41.0% | 296,469 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $6,130,000 | +68.7% | 296,851 | +72.4% | 0.00% | 0.0% |
| Q1 2015 | $3,634,000 | -29.7% | 172,152 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $5,167,000 | +95.1% | 167,869 | +12.0% | 0.00% | 0.0% |
| Q3 2014 | $2,648,000 | – | 149,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |